Medicare Enrolled
Dr. Jianxin Ma, M.D.
Neurology · Auburn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ma?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ma
Dr. Jianxin Ma is a neurology specialist in Auburn, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ma performed 573 Medicare services across 428 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ma received a total of $13,310 from 60 pharmaceutical and/or device companies across 678 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 41% volume in NY
$13,310 industry payments
Medicare Practice Summary
Medicare Utilization ↗573
Medicare services
Top 41% in NY for neurology
428
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~30 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
249 | $61 | $175 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
102 | $70 | $170 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
59 | $97 | $265 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $113 | $320 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $85 | $250 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $78 | $220 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
19 | $120 | $351 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
14 | $150 | $425 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $40 | $110 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
12 | $187 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,310
Total received (2018-2024)
Avg $1,901/year across 7 years
Top 22% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
678
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,285 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,599
2023
$2,674
2022
$2,710
2021
$2,386
2020
$2,128
2019
$645
2018
$167
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$334
ABBVIE INC.
$289
PFIZER INC.
$272
Lundbeck LLC
$207
Lilly USA, LLC
$206
ARGENX US, INC.
$142
Novartis Pharmaceuticals Corporation
$117
Amneal Pharmaceuticals LLC
$112
SK Life Science, Inc.
$111
Genentech USA, Inc.
$82
Otsuka America Pharmaceutical, Inc.
$75
Alexion Pharmaceuticals, Inc.
$70
Teva Pharmaceuticals USA, Inc.
$61
Neurocrine Biosciences, Inc.
$56
MITSUBISHI TANABE PHARMA AMERICA, INC.
$54
CATALYST PHARMACEUTICALS, INC.
$52
Biogen, Inc.
$49
MDD US Operations, LLC
$42
Averitas Pharma Inc.
$39
Kyowa Kirin, Inc.
$38
Celgene Corporation
$37
Alnylam Pharmaceuticals Inc.
$27
Eisai Inc.
$21
Tonix Medicines, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$19
Merz Pharmaceuticals, LLC
$19
BIOTRONIK INC.
$18
Neurelis, Inc.
$17
GE HEALTHCARE
$13
Top 3 companies account for 34.4% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$1,244
ABBVIE INC.
$904
UCB, Inc.
$768
SK Life Science, Inc.
$742
Lilly USA, LLC
$709
Lundbeck LLC
$694
Biogen, Inc.
$611
PFIZER INC.
$580
Celgene Corporation
$511
Amgen Inc.
$475
Amneal Pharmaceuticals LLC
$441
EMD Serono, Inc.
$434
Novartis Pharmaceuticals Corporation
$425
ARGENX US, INC.
$373
Biohaven Pharmaceuticals, Inc.
$350
Alexion Pharmaceuticals, Inc.
$306
Genentech USA, Inc.
$286
E.R. Squibb & Sons, L.L.C.
$249
AbbVie Inc.
$222
Allergan, Inc.
$208
IMPEL PHARMACEUTICALS INC.
$195
GENZYME CORPORATION
$189
Acorda Therapeutics, Inc
$177
Kyowa Kirin, Inc.
$156
Janssen Pharmaceuticals, Inc
$152
Biohaven Pharmaceutical Holding Company Ltd.
$152
Otsuka America Pharmaceutical, Inc.
$132
MITSUBISHI TANABE PHARMA AMERICA, INC.
$128
UPSHER-SMITH LABORATORIES LLC
$106
Neurocrine Biosciences, Inc.
$102
CATALYST PHARMACEUTICALS, INC.
$95
Sunovion Pharmaceuticals Inc.
$89
Horizon Therapeutics plc
$87
LivaNova USA, Inc.
$83
MDD US Operations, LLC
$71
Avanir Pharmaceuticals, Inc.
$68
GE HealthCare
$64
Adamas Pharmaceuticals, Inc.
$60
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$57
Assertio Therapeutics, Inc.
$50
ACADIA Pharmaceuticals Inc
$50
Alnylam Pharmaceuticals Inc.
$49
US WorldMeds, LLC
$48
Upsher-Smith Laboratories LLC
$41
Grifols USA, LLC
$40
Averitas Pharma Inc.
$39
Eisai Inc.
$37
Takeda Pharmaceuticals U.S.A., Inc.
$33
BANNER LIFE SCIENCES, LLC
$32
Xeris Pharmaceuticals, Inc.
$25
Bardy Diagnostics, Inc.
$22
Tonix Medicines, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$19
Merz Pharmaceuticals, LLC
$19
BIOTRONIK INC.
$18
Aprecia Pharmaceuticals, LLC
$18
Neurelis, Inc.
$17
Avion Pharmaceuticals
$14
GE HEALTHCARE
$13
Amarin Pharma Inc.
$11
Top 3 companies account for 21.9% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BIOMONITOR · BOTOX · BOTOX COSMETIC · Briviact · CAMBIA · COMIRNATY · CREXONT · Carnation Ambulatory Monitor · Dhivy · EMGALITY · ENTYVIO · Enspryng · Entyvio · FIRDAPSE · GOCOVRI · GVOKE PFS · Gamunex-C · Gocovri · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONPATTRO · Ocrevus · PAXLOVID · QULIPTA · QUTENZA · RADICAVA · REXULTI · REYVOW · RYTARY · Repatha · Rystiggo · SOLIRIS · SPINRAZA · Soliris · Spritam · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRULANCE · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vascepa · XADAGO · XCOPRI · XIFAXAN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
51
Per 100K population
67.6
County median income
$66,583
Nearest hospital
AUBURN COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ma is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ma experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Ma performed 249 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ma receive payments from pharmaceutical companies?
Yes. Dr. Ma received a total of $13,310 from 60 companies across 678 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ma's costs compare to other neurologists in Auburn?
Dr. Ma's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Auburn
Browse neurologists in Auburn ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology